Bristol Myers Squibb Co. (BMY)
66.79
+0.21
(+0.32%)
USD |
NYSE |
Aug 31, 16:00
66.94
+0.15
(+0.22%)
After-Hours: 20:00
Bristol Myers Squibb Cash from Operations (Annual) : 14.16B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.16B |
| December 31, 2024 | 15.19B |
| December 31, 2023 | 13.86B |
| December 31, 2022 | 13.07B |
| December 31, 2021 | 16.21B |
| December 31, 2020 | 14.05B |
| December 31, 2019 | 8.067B |
| December 31, 2018 | 5.94B |
| December 31, 2017 | 5.275B |
| December 31, 2016 | 2.85B |
| December 31, 2015 | 1.832B |
| December 31, 2014 | 3.148B |
| December 31, 2013 | 3.545B |
| December 31, 2012 | 6.941B |
| December 31, 2011 | 4.84B |
| December 31, 2010 | 4.491B |
| December 31, 2009 | 4.065B |
| December 31, 2008 | 3.707B |
| December 31, 2007 | 3.153B |
| December 31, 2006 | 2.083B |
| December 31, 2005 | 1.836B |
| December 31, 2004 | 3.176B |
| Date | Value |
|---|---|
| December 31, 2003 | 3.512B |
| December 31, 2002 | 945.00M |
| December 31, 2001 | 5.402B |
| December 31, 2000 | 4.652B |
| December 31, 1999 | 4.47B |
| December 31, 1998 | 4.12B |
| December 31, 1997 | 2.476B |
| December 31, 1996 | 2.641B |
| December 31, 1995 | 2.499B |
| December 31, 1994 | 2.301B |
| December 31, 1993 | 2.58B |
| December 31, 1992 | 2.028B |
| December 31, 1991 | 1.835B |
| December 31, 1990 | 1.752B |
| December 31, 1989 | 1.19B |
| December 31, 1988 | 980.60M |
| December 31, 1987 | 711.80M |
| December 31, 1986 | 671.30M |
| December 31, 1985 | 626.20M |
| December 31, 1984 | 459.80M |
| December 31, 1983 | 532.40M |
| December 31, 1982 | 505.70M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Pfizer Inc. | 11.70B |
| AstraZeneca PLC | 14.90B |